T1	Participants 74 86	osteoporosis
T2	Participants 407 419	multi-center
T3	Participants 478 654	Consecutive post-menopausal women aged 50 years to 86 years starting treatment with raloxifene according to daily practice were enrolled from 126 primary care offices in Spain.
T4	Participants 659 664	women
T5	Participants 931 1028	A total of 745 post-menopausal women (group A, n=366; group B n=379), with a mean age of 62 years
T6	Participants 1701 1751	young post-menopausal women suffering osteoporosis
